Novartis AG (VIE:NOVN)

Market Cap	248.55B +28.7%
Revenue (ttm)	48.27B +9.6%
Net Income	11.91B +17.1%
EPS	6.09 +21.8%
Shares Out	n/a
PE Ratio	20.87
Forward PE	17.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	128.10
Previous Close	126.90
Day's Range	126.92 - 128.10
52-Week Range	94.21 - 126.92
Beta	n/a
RSI	67.95
Earnings Date	Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: NOVN

Financial Performance

In 2025, Novartis AG's revenue was $56.67 billion, an increase of 9.57% compared to the previous year's $51.72 billion. Earnings were $13.98 billion, an increase of 17.11%.

Financial numbers in USD